Notice of Results
October 22 2008 - 5:00AM
UK Regulatory
RNS Number : 4131G
GW Pharmaceuticals PLC
22 October 2008
GW Pharmaceuticals plc
Notification of Results
Porton Down, UK, 22 October 2008: GW Pharmaceuticals plc (AIM: GWP) will be announcing its preliminary financial results for the year to
30 September 2008 on Tuesday 18 November 2008.
Enquiries:
Financial Dynamics 020 7831 3113
Ben Atwell
Notes to Editors
About GW
GW was founded in 1998 and listed on the AiM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK
Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious
ailments, in particular pain and other neurological symptoms. GW has assembled a team of over 100 scientists with extensive experience in
developing both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading
position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field.
For further information, please visit the Company's website: www.gwpharm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORVLLBLVBBXFBV
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More GW Pharmaceuticals News Articles